- Home
- Kostenlose App-Analyse
- Dnsys
- Dnsys Vs. UTSW Cancer Clinical Trials
Dnsys im Vergleich zu UTSW Cancer Clinical Trials Nutzung und Statistiken
Dnsys is the exclusive application designed for controlling Dnsys's smart exoskeleton devices. It supports easy connection to the exoskeleton via Bluetooth, allowing users to view the status of the exoskeleton and set parameters. With a variety of unique interaction modes, Dnsys helps you see farther horizons and experience the joy of technology-enhanced exercise.
【Assist Mode】 The AI embedded in the exoskeleton predicts your muscle exertion in real-time, providing a comfortable assist that makes exercising more effortless. Within the app, you can customize and adjust the preferred level of assistance and speed.
【Boost Mode】 It offers an instant surge of powerful assistance, turning you into a “Speedster” and enabling you to reach unprecedented running speeds (this feature is exclusive to the Pro version of the exoskeleton device).
【Resistance Mode】 Simulating water resistance, this mode scientifically loads and trains your thigh muscle groups, providing a comprehensive workout regimen.
- Apple App Store
- Kostenlos
- Gesundheit und Fitness
Rang speichern
- -
Find a Clinical Trial is a tool for volunteers looking to join a research study at UT Southwestern Medical Center. Users can search studies that are recruiting participants by specific medical conditions or by typing in terms to find studies that match their needs.
- Apple App Store
- Kostenlos
- Medizin
Rang speichern
- -
Dnsysvs. UTSW Cancer Clinical Trials Ranking-Vergleich
Vergleichen Sie Dnsys den Ranking-Trend der letzten 28 Tage mit UTSW Cancer Clinical Trials
Rang
Keine Daten verfügbar
Dnsys im Vergleich zu UTSW Cancer Clinical Trials Ranking im Ländervergleich
Vergleichen Sie Dnsys den Ranking-Trend der letzten 28 Tage mit UTSW Cancer Clinical Trials
Keine Daten zum Anzeigen
Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an
Dnsys VS.
UTSW Cancer Clinical Trials
Januar 8, 2025